Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives

Acute myeloid leukemia (AML) with NPM1 gene mutations is currently recognized as a distinct entity, due to its unique biological and clinical features. We summarize here the results of published studies investigating the clinical application of minimal/measurable residual disease (MRD) in patients w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Autores principales: Forghieri, Fabio, Comoli, Patrizia, Marasca, Roberto, Potenza, Leonardo, Luppi, Mario
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6274702/
https://ncbi.nlm.nih.gov/pubmed/30404199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113492
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares